The adverse effects included hallucinations, vomiting, tremor, anxiety, dizziness, confusion and loss of consciousness, the Agency said. HealthDay News — In a joint effort to curb the illegal sales of ...

HealthDay News — For individuals with mild-to-moderate hearing loss, self-fit over-the-counter (OTC) hearing aids offer comparable long-term benefits to audiologist-fit hearing aids, according to a ...

Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells. The Food and Drug Administration (FDA) has accepted for Priority Review the ...

The analysis included 7 years of prescription drug claims data for 129,997 individuals with T2D identified from the TriNetX Diamond Network. HealthDay News — As people with diabetes age into Medicare, ...

Ofatumumab is more effective than teriflunomide for relapsing multiple sclerosis across subgroups. HealthDay News — For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective ...

"Use of an extended-release oral dosage ketamine formulation may be advantageous compared with intranasal or intravenous dosing." HealthDay News — For patients with treatment-resistant depression, ...

Over the 52 week study period, the safety profile of CAM2029 was found to be consistent with first generation somatostatin ...

A packaging error has prompted the recall of 1 lot of Endo’s Clonazepam Orally Disintegrating Tablets. The product is being recalled because the incorrect strength of 0.125mg is appearing on the ...

During the omicron era, hospital-onset SARS-CoV-2 infection remained associated with increased morbidity and mortality, ...

Stiff person syndrome is a rare autoimmune neurological disorder that causes progressive muscle stiffness in the torso, arms, ...

Metformin displayed lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had highest risk ...

A Prescription Drug User Fee Act target date of December 20, 2024 has been set for the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...